CD8A and cancer: Similarly, IFN‐γ production from CD8+ T cells co‐cultured with CT26 cancer cells was increased by sICAM‐1 and anti‐PD‐1 alone and additively enhanced by combining sICAM‐1 and anti‐PD‐1 (Figure 2g).